A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone
Clinical trial NCT04965272 · WITHDRAWN
Trial details
- NCT number
- NCT04965272
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2021-08-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.